Proactive vs. Reactive Quality: Building a Business Case for Quality Investments

Presented November 14, 2024

Download our insightful discussion on the importance of proactive quality approaches and reducing the hidden costs of poor quality.

Stephanie shared a few slides on the cost of quality as a primer for the Q&A discussion and answered questions submitted by the audience, such as:

  • Why is a reactive approach commonly used to fulfill regulatory compliance?
  • How can I convince management to invest in quality improvements?
  • How do we transition from reactive to proactive quality measures?

Get to know the speakers

Stephanie Gaulding, CPGP, CQA – Managing Director at Pharmatech Associates

Stephanie Gaulding

Managing Director at Pharmatech Associates

Ryan Donohue – VP of Sales

Ryan Donohue

VP of Sales

If you have trouble with the form, please contact events@redica.com.

Register for the webinar

Access the replay

If you have trouble with the form, please contact events@redica.com.